Financial Performance - Revenue decreased by 4.1% year-over-year to $144.3 million[6] - Net income decreased by 35.5% year-over-year to $7.8 million[6] - Adjusted net income decreased by 25.9% year-over-year to $10.9 million[6] - Diluted EPS decreased by 28.6% year-over-year to $0.25[6] - Adjusted diluted EPS decreased by 18.6% year-over-year to $0.35[6] - Adjusted EBITDA decreased by 15.0% year-over-year to $21.6 million[6] Operational Metrics - Active and unique customers decreased by 1.6% year-over-year to approximately 3.5 million[9] - Money transfer transactions decreased by 5.2% year-over-year to 12.8 million[9] - Total principal sent increased by 3.7% year-over-year to $5.6 billion[9] - Digital transactions increased by 68.5% year-over-year to 0.8 million[9] - Revenue from digital transactions increased by 29.8% year-over-year to $4.9 million[9] Liquidity and Capital Allocation - Cash and cash equivalents were $152 million[19] - Undrawn revolver capacity at March 31 was $278 million[19] - Total debt was $147 million[20] - Debt to Adjusted EBITDA (trailing twelve months) was 1.3x[20] - $5.0 million was allocated to stock buybacks in Q1 2025[24] 2025 Outlook - The company projects revenue between $634.9 million and $654.2 million[27] - The company projects Adjusted EBITDA between $103.6 million and $106.8 million[27] - The company projects Diluted EPS between $1.53 and $1.65[27] - The company projects Adjusted Diluted EPS between $1.86 and $2.02[27]

Q120First Quarter 2025 Financial Results v Safe Harbor Statement The Private Securities Litigation Reform Act of 1995, as amended, (the "Act"), provides protection from liability in private lawsuits for "forward-looking" statements made by public companies under certain circumstances, provided that the public company discloses with specificity the risk factors that may impact its future results. The Company wants to take advantage of the "safe harbor" provisions of the Act. Certain statements made during th ...

Quarter Ended March 31, 2025 Supplementary Information to the May 7, 2025, Earnings Conference Call & Webcast Lasting relationships. Global success. Kimball Electronics Third Quarter Fiscal 2025 Results Safe Harbor Statement Certain statements contained within this supplementary information, including our fiscal year 2025 guidance, and any statements made during our earnings conference call today may be considered forward-looking under the Private Securities Litigation Reform Act of 1995. The statements may ...

Investor Presentation May 2025 Safe Harbor This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements made herein that are not statements of historical fact, including statements about Radware's plans, outlook, beliefs, or opinions, are forward-looking statements. Generally, forward-looking statements may be identified by words such as "believes," "expects," "anticipates," "intends," "estimates," "plans," and similar exp ...

FIRST QUARTER 2025 EARNINGS CONFERENCE CALL FORWARD LOOKING STATEMENTS Some statements in this release, which are not historical facts, are "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Forward- looking statements include statements about Arcosa's estimates, expectations, beliefs, intentions or strategies for the future. Arcosa uses the words "anticipates," "assumes," "believes," "estimates," "expects," "intends," "forecasts," "may," "will," "should," "guid ...

An International Alternative Asset Manager FIRST QUARTER 2025 INVESTOR PRESENTATION TRINITYCAPITAL.COM NASDAQ: TRIN FORWARD-LOOKING STATEMENTS | DISCLAIMER Trinity Capital Inc. (the "Company") cautions that this presentation may contain forward-looking statements that are based on current expectations and assumptions about future events, and which are not based in historical fact. The forward-looking statements in this presentation are based on current conditions as of the date of this presentation, and inc ...

Financial Performance - Q3 2025 - Net sales reached $76 million[18], a decrease of 10% compared to Q3 FY24[20] - Adjusted EBITDA amounted to $75 million[18], down from $117 million in Q3 FY24[20] - Adjusted diluted net income per share was $030[18], a decrease from $050 in Q3 FY24[20] Financial Performance - YTD Q3 2025 - YTD net sales totaled $2047 million[22], a 24% decrease from FY24[22] - YTD Adjusted EBITDA was $149 million[22], down from $386 million in FY24[22] - YTD Adjusted Diluted Net Income per Share was $053[22], down from $112 in FY24[22] Balance Sheet & Capital Allocation - The company maintains a strong financial position with approximately $67 million in cash and investments and no debt[18] - The company returned $5 million of capital YTD through a share repurchase program[18] - The company authorized a $50 million share repurchase program in July 2023, with approximately $30 million still available[26] Fiscal Year 2025 Guidance - The company refines fiscal 2025 guidance with net sales of approximately $275 million[18] - The company projects adjusted EBITDA of approximately $20 million[18] - The company anticipates adjusted earnings per share of approximately $071[18]

Changes to Key Metrics Q1 2025 Primer 1 Change of Metric from Transacting Professionals to Active Pros A key sign of Pro engagement on our platform is Pros making themselves available to be presented to homeowners for particular Service Requests and paying for the corresponding Leads if selected by the homeowner. We've redesigned the metric - Average Monthly Active Pros - to best capture that activity. The current Transacting Professional metric is focused on whether a Pro has generated revenue during the q ...

TPG has declared a quarterly dividend of $0.41 per share of Class A common stock to holders of record at the close of business on May 19, 2025, payable on June 2, 2025. Conference Call TPG will host a conference call and live webcast at 11:00 am ET. It may be accessed by dialing (800) 245-3047 (US toll-free) or (203) 518-9765 (international), using the conference ID TPGQ125. The number should be dialed at least ten minutes prior to the start of the call. A simultaneous webcast will also be available and can ...

Business Highlights - BeiGene's Q1 2025 execution sets a strong foundation for the year, focusing on hematology franchise leadership, pipeline advancement, and superior financial performance[11] - Brukinsa is now the U S revenue leader among BTKis, with over 200,000 patients treated globally[17] - BeiGene has launched Brukinsa in Japan and it is now approved in 75 markets, with 11 new or expanded reimbursements including in Japan, EU, and Brazil[21] - Enrollment is complete in the Phase 3 CELESTIAL-TNCLL trial for Sonrotoclax, with global filing expected in R/R MCL in H2 2025[23] - BeiGene achieved GAAP profitability in Q1 2025, with GAAP Operating Income of $11 million compared to a loss of $261 million in Q1 2024[40] Financial Performance - Total revenue for Q1 2025 increased by 49% year-over-year, reaching $1.117 billion, compared to $752 million in Q1 2024[93, 95] - Net product revenue in Q1 2025 was $1.109 billion, a 48% increase from $747 million in Q1 2024[95, 96] - Brukinsa revenue in Q1 2025 reached $792 million, a 62% increase from $489 million in Q1 2024[95] - Tevimbra revenue in Q1 2025 was $171 million, an 18% increase from $145 million in Q1 2024[95] - GAAP earnings per ADS was $0.01 in Q1 2025, compared to a loss of $2.41 in Q1 2024[96]